Advanced search
Publication Cover
Current Eye Research Volume 7, 1988 - Issue 5
Submit an article Journal homepage
5
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Immunological analysis of a destructive pattern of intraocular tumor resolution

Jerry Y. Niederkorn Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Mines Boulevard, Dallas, TX, 75235–9057, USA
&
Terrence L. Knisely Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Mines Boulevard, Dallas, TX, 75235–9057, USA
Pages 515-526 | Received 05 Feb 1988, Accepted 28 Mar 1988, Published online: 02 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kyle C. McKenna & Peter W. Chen. (2010) Influence of Immune Privilege on Ocular Tumor Development. Ocular Immunology and Inflammation 18:2, pages 80-90.
Read now
Xiao-Yan Li, Elizabeth Mayhew & Jerry Y. Niederkorn. (1995) Anti-leukocyte function-1 antibody treatment prevents the rejection of intraocular regressor tumors and their metastases. Current Eye Research 14:8, pages 719-726.
Read now

Articles from other publishers (14)

Terry G Coursey, Peter W Chen & Jerry Y Niederkorn. (2012) IFN-γ-independent intraocular tumor rejection is mediated by a macrophage-dependent process that leaves the eye intact. Journal of Leukocyte Biology 92:5, pages 939-950.
Crossref
Terry G. Coursey, Peter W. Chen & Jerry Y. Niederkorn. (2011) IL-17–Dependent, IFN-γ–Independent Tumor Rejection Is Mediated by Cytotoxic T Lymphocytes and Occurs at Extraocular Sites, but Is Excluded from the Eye. The Journal of Immunology 187:8, pages 4219-4228.
Crossref
Terry G. Coursey, Peter W. Chen & Jerry Y. Niederkorn. (2011) Abrogating TNF-α Expression Prevents Bystander Destruction of Normal Tissues during iNOS-Mediated Elimination of Intraocular Tumors. Cancer Research 71:7, pages 2445-2454.
Crossref
Jerry Y. Niederkorn. (2009) Immune escape mechanisms of intraocular tumors. Progress in Retinal and Eye Research 28:5, pages 329-347.
Crossref
Peter W. Chen, Tohishiko Uno & Bruce R. Ksander. (2006) Requirement of CD80+ costimulation for rejection of ocular tumors and termination of immune privilege. Experimental Eye Research 83:3, pages 574-583.
Crossref
Shixuan Wang, Zita F. H. M. Boonman, Hao-Chuan Li, YuGuang He, Martine J. Jager, Rene E. M. Toes & Jerry Y. Niederkorn. (2003) Role of TRAIL and IFN-γ in CD4+ T Cell-Dependent Tumor Rejection in the Anterior Chamber of the Eye. The Journal of Immunology 171:6, pages 2789-2796.
Crossref
Jeffrey I. Everitt, John A. Shadduck & Herbert E. Whiteley. 2002. Ocular Tumors in Animals and Humans. Ocular Tumors in Animals and Humans 435 447 .
Thomas J. D'Orazio & Jerry Y. Niederkorn. (1998) The nature of antigen in the eye has a profound effect on the cytokine milieu and resultant immune response. European Journal of Immunology 28:5, pages 1544-1553.
Crossref
Thomas J. D’Orazio & Jerry Y. Niederkorn. (1998) A Novel Role for TGF-β and IL-10 in the Induction of Immune Privilege. The Journal of Immunology 160:5, pages 2089-2098.
Crossref
Jerry Y. Niederkorn. (1995) The immunopathogenesis of ocular tumors. Progress in Retinal and Eye Research 14:2, pages 505-526.
Crossref
George L. Stewart, Jerry Y. Niederkorn, Rebecca R. Kennedy & Elizabeth Mayhew. (1991) Effect of acute versus chronic Trichinella pseudospiralis infections on systemic cell-mediated immunity. International Journal for Parasitology 21:8, pages 935-940.
Crossref
J Y Niederkorn. (1991) The immunopathology of intraocular tumour rejection. Eye 5:2, pages 186-192.
Crossref
Terrence L. Knisely & Jerry Y. Niederkorn. (1990) Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye. Cancer Immunology Immunotherapy 30:6, pages 323-330.
Crossref
Jerry Y. Niederkorn. 1990. Advances in Immunology Volume 48. Advances in Immunology Volume 48 191 226 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.